AGP Executive Report
Last update: 2 hours agoEbola Crisis Escalates: WHO says the DRC’s Bundibugyo Ebola outbreak is the fastest-growing ever, with most new cases coming from “unknown chains,” and warns the true scale could be 2–4 times higher than official figures. Health System Under Strain: Health workers at an Ebola treatment centre in Ituri threatened a strike over unpaid wages, as many deaths are reported in communities before patients reach care. Funding Crunch: WHO says it has received less than half of the $115m it needs for the first six months, urging donors not to abandon DRC. Cross-Border Risk: South Sudan is scrambling to prevent importation as the outbreak advances across DRC provinces; Uganda also calls for sustained international support. New Countermeasures: Oxford has begun phase 1 human trials for a Bundibugyo vaccine in the UK, while researchers in DRC are enrolling participants in a trial of Gilead’s experimental antiviral obeldesivir as post-exposure treatment. Travel Curbs: The US has barred Americans in/near DRC from boarding commercial flights home unless they spend 21 days in a third country. Economy & Industry: Alphamin reports record Q2 EBITDA guidance and steady tin output in the DRC, while industry warns planned mining law reforms could dent investor confidence.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
